Fierce Biotech News & Reports
WEB4 days ago · Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
Biotech | Fierce Biotech
WEBFeb 12, 2024 · After a small downsizing this summer, Relay is now shedding about 10% of its workforce. Gabrielle Masson Oct 3, 2024 4:23pm. Connect. The Team. Advertise. Join Us. Newsletters. Resources. RSS Feeds.
Introducing Fierce Biotech's 2024 Fierce 15
WEBWelcome to the 2024 Fierce 15. The Fierce Biotech editorial team is proud to present this class of the best in biotech. These 15 companies were carefully selected from hundreds of nominees. This ...
About Us - Fierce Biotech
WEBAbout Us. Biopharma is a fast-growing world where big ideas come along daily. Our readers rely on Fierce Biotech for the latest news, analysis and data on drugs and the companies that make them ...
Research - Fierce Biotech
WEBSep 26, 2024 · The California-based biotech will work to clinically develop and manufacture antibodies that target seven botulinum toxin variants. Darren Incorvaia Oct 3, 2024 8:00am. Connect.
Pharma - Fierce Biotech
WEB6 days ago · Lundbeck has partnered with Charles River to use the Logica AI platform in the discovery of neuroscience treatments. Nick Paul Taylor Oct 2, 2024 9:21am. Connect.
Welcome to the new and improved FierceBiotech | Fierce Biotech
WEBApr 10, 2016 · Welcome to the new and improved FierceBiotech. By Rebecca Willumson Apr 10, 2016 2:14pm. Publisher's Note FierceBiotech Rebecca Willumson Research. We are pleased to introduce you to the ...
Sanofi-backed Escient scores $120M series C for neuro …
WEBNov 28, 2022 · Escient Pharmaceuticals has scored $120 million, a much heftier sum than its series B haul from a few years ago and once again snagging support from Big Pharma Sanofi’s VC arm.. The series C ...
Clinical Data - Fierce Biotech
WEBSep 25, 2024 · Gritstone bio brought in bankers after its phase 2 colorectal cancer vaccine data fell short of the runaway success needed to transform its fortunes. Nick Paul Taylor Oct 1, 2024 10:07am. Connect.
Fierce Pharma Biopharma News & Insights - Fierce Biotech
WEBFeb 7, 2012 · Genentech is taking ownership of a breast cancer candidate that has shown signs of single-agent efficacy in patients failed by existing options. Nick Paul Taylor Sep 30, 2024 02:30am.